N-glycosidesindolo[2,3,-a]pyrrolo[3,4,-c]carbazole derivatives chemical structure influence on antitumor activity
- Authors: Kiseleva M.P.1, Pokrovsky V.S.2,3, Borisova L.M.1, Golubeva I.S.1, Ektova L.V.1
-
Affiliations:
- N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia.
- N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia
- Peoples’ Friendship University of Russia.
- Issue: Vol 18, No 2 (2019)
- Pages: 32-39
- Section: ORIGINAL REPORTS
- Published: 15.06.2019
- URL: https://bioterapevt.abvpress.ru/jour/article/view/1154
- DOI: https://doi.org/10.17650/1726-9784-2019-18-2-32-39
- ID: 1154
Cite item
Full Text
Abstract
Introduction . The report considers the prospect of rational approach to the new anticancer agents creation based on indolocarbazole derivatives.
Objective . To conduct a comparative study of 12 domestic N-glycosides, indolo[2,3-a]pirrolo[2,3-a]carbazole derivatives in the course of “structure – activity” bond analysis.
Materials and methods . The investigation of influence of 12 carbohydrate – containing indolocarbazoles, synthesized in N. N. Blokhin Russian Cancer Research Center of the Ministry of Health of Russia, performed on models of solid transplantable mouse tumors: lung Lewis epidermoid carcinoma and B16 melanoma. The antitumor effect was assessed by Lewis epidermoid carcinoma and B16 melanoma tumor growth inhibition (TGI %) criterion.
Results . A variety of indolocarbazoles modifications allowed revealing the dependence of their antitumor properties on the structure of both, the aglycone and the glycoside residue. Imino-nitrogen interchange of atoms in upper heterocycle influences on indocarbazole derivatives antitumor activity change. During a comparative study of 12 N-glycosides indolocarbazole derivatives on lung Lewis epidermoid carcinoma and B16 melanoma models, 8 derivatives showed antitumor activity.
Conclusion . The formulated concepts on the modification features in indolocarbazole derivatives structure can be used for more active compounds creation with greater action selectivity.
About the authors
M. P. Kiseleva
N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia.
Author for correspondence.
Email: marina-kiselyova@mail.ru
24 Kashirskoe Sh., Moscow 115478. Russian Federation
V. S. Pokrovsky
N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia; Peoples’ Friendship University of Russia.
ORCID iD: 0000-0003-4006-9320
24 Kashirskoe Sh., Moscow 115478; 6 Miklukho-Maklaya St., Moscow 117198. Russian Federation
L. M. Borisova
N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia.24 Kashirskoe Sh., Moscow 115478. Russian Federation
I. S. Golubeva
N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia.24 Kashirskoe Sh., Moscow 115478. Russian Federation
L. V. Ektova
N. N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of Russia.24 Kashirskoe Sh., Moscow 115478. Russian Federation
References
Supplementary files

